Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial
暂无分享,去创建一个
J. Harvey | C. Kirwan | A. Marshall | J. Thachil | C. Palmieri | N. Bundred | K. Cox | C. Holcombe | J. Castle | E. Blower | S. Cicconi